Botulinum Toxin a for the Management of Interstitial Cystitis/Bladder Pain Syndrome

Herald Urology
doi 10.21886/2308-6424-2017-5-3-68-78
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Rostov State Medical University

Related search

Interstitial Cystitis/Bladder Pain Syndrome: A Urologic Mystery

International Neurourology Journal
NeurologyUrology
2006English

Pharmacologic Management of Painful Bladder Syndrome/Interstitial Cystitis

Archives of Internal Medicine
2007English

Re: Hydrodistention of the Bladder for the Treatment of Bladder Pain Syndrome/Interstitial Cystitis (BPS/IC)

Journal of Urological Surgery
2017English

Mirabegron as Adjuvant Treatment for Patients With Interstitial Cystitis/Bladder Pain Syndrome

Canadian Urological Association Journal
Urology
2017English

Perceptions of “Urgency” in Women With Interstitial Cystitis/Bladder Pain Syndrome or Overactive Bladder

Neurourology and Urodynamics
NeurologyUrology
2010English

Validation of a Quality-Of-Life Scale for Women With Bladder Pain Syndrome/Interstitial Cystitis

Quality of Life Research
EnvironmentalPublic HealthOccupational Health
2011English

Interstitial Cystitis/Bladder Pain Syndrome: The Evolving Landscape, Animal Models and Future Perspectives

International Journal of Urology
Urology
2020English

Overactive Bladder and Bladder Pain Syndrome/Interstitial Cystitis in Primary Sjögren’s Syndrome Patients: A Nationwide Population-Based Study

PLoS ONE
Multidisciplinary
2019English

The Overlap of Interstitial Cystitis/Painful Bladder Syndrome and Overactive Bladder

Journal of the Society of Laparoendoscopic Surgeons
Surgery
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy